Phase I : CardiaBase has developed a recognised know-how in ECG analysis for Phase I studies, with adapted services for Phase I stakes: - Specific device installation in the Phase I unit with teletransmission of ECGs from Phase I unit to CardiaBase, - ECG analysis with short turnaround time (up to 24hrs) for screening or safety purposes, - Weekly report with senior cardiologist attendance to dose escalation meetings   Phase II and III: CardiaBase provides ECG analysis for Phase II and III studies with : - Multi-site equipment management - Teletransmission of ECGs - Online ECG analysis with appropriate turnaround time (up to 24hrs) - Multiple reports to sites, country management and sponsor CardiaBase provides ECG and Holter recorders, teletransmission of recordings and online analysis.

12-lead continuous ECG recording (up to 72-hrs) is available, with a possibility to extract multiple sequences of 10s ECGs out of the holter recording. CardiaBase provides worldwide site equipment with :   On site training with ECG device, Specific device programming with study features, Teletransmission set up between site and CardiaBase, Worldwide kick off meetings and device set up Hotline with full tracking of device and consumables supply throughout the study Specific Phase III project management